ASAM Lead Coalition Letter Voicing Concern About Comments by HHS Secretary Tom Price
ASAM led a coalition letter to HHS Secretary Tom Price expressing concern about comments he made in West Virginia suggesting that some forms of medication for opioid use disorder are superior to others, and that some are just replacing one opioid with another. The letter emphasizes how all three medications r approved by the FDA to treat opioid use disorder and are safe, effective, and help patients enter and sustain recovery and regain control of their lives.